The Resistant Hypertension Course (“RHC”) Board is pleased to announce that Costas Tsioufis (Assistant Professor of Cardiology, University of Athens, Chief of Hypertension Unit, First Cardiology Clinic, University of Athens, Greece) is joining Felix Mahfoud as Co-Chairperson of the RHC 2014. Costas Tsioufis will represent the European Society of Hypertension, where he currently holds the position of Secretary.
Sebastian Ewen asks questions to Stefan C. Bertog, first author of Renal denervation: tips and tricks to perform a technically successful procedure, article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013.
The Symplicity HTN-1 (n=150) was the first multicenter, proof-of-concept and safety study for patients with resistant arterial hypertension (mean age 57 years) undergoing catheter-based renal denervation. Patients in the Symplicity HTN-1 study were heavily medicated, taking an average of five antihypertensive drugs, and were still poorly controlled (office blood pressure 175/98mmHg). The primary endpoint was peri-procedural and safety of the treatment (n=45) after 1 and 12 month published in 2009 at the Lancet (1).
Arterial hypertension is the single largest contributor to death worldwide. One in three adults (around 1 billion people) worldwide are affected and the number is expected to increase to 1.6 billion by 2025. Data from the World Health Organization (WHO) Southeast Asian regions indicate that the prevalence of hypertension (blood pressure ≥ 140/90mmHg) ranging from 5% to 47% in men and 7% to 38% in women causing up to 66% of cardiovascular diseases, including fatal ischemic heart disease and stroke.
Sebastian Ewen asks questions to Sebastian A. Potthoff, first author of The “resistant hypertension team”: focus on a multidisciplinary approach to hypertension article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013.
Sebastian Ewen asks questions to Christian Ott, first author of " Ruling out secondary causes of hypertension " article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013.
Markus Schlaich, Course Director, answers the following questions:
- What are the objectives of the RHC Asia Pacific course?
- What are reasons to participate in RHC Asia Pacific?
"This very educational and interactive course is endorsed by various societies and we will make sure it is very practical and the information you'll get will be easy to implement into your practical daily activities."
Renal Sympathetic Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients with Resistant Hypertension
Find out what will be new and what you will find on this new version with Atul Pathak and Sebastian Ewen, members of the editorial board:
- What will be found on RHCourse online website? by Sebastian Ewen
- What is the raison d'être of RHCourse online website? by Atul Pathak
"The most important thing is that this website will be a real link, it will create a community of people who are interested and want to share their experience and their knowledge about resistant hypertension."